hat
Treeway konpayi an biotech ap devlope yon fòmil oral nan edaravone (TW001) epi li se kounye a nan devlopman nan klinik. Treeway te akòde deziyasyon dwòg òfelen pou Edaravone pa EMA a nan mwa Novanm 2014 ak FDA nan mwa janvye 2015.Wot baj: 4-Aminopyridine .
eng
The biotech company Treeway is developing an oral formulation of edaravone (TW001) and is currently in clinical development. Treeway was awarded orphan drug designation for edaravone by the EMA in November 2014 and FDA in January 2015.Hot tags: 4-Aminopyridine .